Novo CEO blasts ‘mass compounding’ of GLP-1 drugs as safety battle escalates
Fox Business | Business News & Stock Quotes - Saving & Investin…
February 11, 2026
Novo Nordisk’s CEO says compounded GLP-1 knockoffs sourced from overseas ingredients could endanger patients and undermine FDA oversight as legal battle escalates.
Discussion in the ATmosphere